Results 231 to 240 of about 99,381 (320)

Should Prediabetes Be Classified as a Treatable Disease? [PDF]

J Clin Med
Winter WE, Jialal I.
europepmc   +1 more source

Prediabetes [PDF]

Postgraduate Medical Journal, 1959
openaire   +1 more source

The Natural History of Prediabetes and Cardiovascular Disease in the Pediatric Population. [PDF]

Biomedicines
Accacha S, Barillas-Cerritos J, Gabriel L, Srivastava A, Gulkarov S, Apsan JA, De Leon J, Reiss AB.   +7 more
europepmc   +1 more source

Exploring Uric Acid to HDL Ratio as a Long‐Term Biomarker for Diabetes Mellitus

Journal of Clinical Laboratory Analysis, Volume 40, Issue 5, March 2026.
This study explores the predictive value of the serum uric acid to HDL cholesterol ratio (UHR) for diabetes mellitus (DM) using data from the decade‐long MASHAD cohort. Elevated UHR levels were significantly associated with increased DM risk, with gender‐specific thresholds identified through ROC analysis. These findings support UHR as a promising long‐
Rana Kolahi, Reza Khademi, Mahboobeh Ghasemzadeh Rahbardar, Niloofar Shabani, Habibollah Esmaily, Nazanin Akbari, Reyhane Alizadeh, Malihehsadat Abedsaeidi, Sara Saffar Soflaei, Majid Ghayour‐Mobarhan   +9 more
wiley   +1 more source

Exploring the multifaceted roles of beta-defensins in prediabetes: a detailed review. [PDF]

Front Endocrinol (Lausanne)
Almansour N, Hasan A, Albeloushi S, Ahmad R.   +3 more
europepmc   +1 more source

Designing and Psychometric Properties of Self‐Care Tool for Adults With Pre‐Diabetes: Exploratory Sequential Mixed Method

Nursing Open, Volume 13, Issue 3, March 2026.
ABSTRACT Background Self‐care is one of the most critical factors in disease prevention. Adults with pre‐diabetes are at 5 to 15 times higher risk of developing type 2 diabetes compared with others. Without self‐care behaviours to promote health and prevention, more than 70% will ultimately develop type 2 diabetes during their lives.
Mozhgan Jokar, Abbas Ebadi, Amir Abbas Momenan, Mahboubeh Sadat Yousefi, Mitra Zandi   +4 more
wiley   +1 more source

Weekly Subcutaneous VK2735, a GIP/GLP‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study

Obesity, Volume 34, Issue 3, Page 537-549, March 2026.
Four doses of VK2735 and a placebo group were included in the VENTURE study. Adults who were overweight or had obesity had significant weight loss when taking any dose of VK2735 for 13 weeks. More people lost at least 10% of their body weight as the dose increased.
Harold E. Bays, Phillip Toth, Naim Alkhouri, John Pullman, Bradley Freilich, Joel Neutel, Summer Ji, Scott Stubbe, Parke Hedges, Brian Lian   +9 more
wiley   +1 more source

Trends in the Incidence of Pediatric Type 1 Diabetes, Type 2 Diabetes, and Prediabetes Before and During the COVID-19 Pandemic. [PDF]

Public Health Rep
Jacobs J, Kim S, Sheu YS, Chesbrough K, Bishop RC, Weinfield NS.   +5 more
europepmc   +1 more source

Addition of Phentermine‐Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double‐Blind Randomized Clinical Trial

Obesity, Volume 34, Issue 3, Page 524-536, March 2026.
ABSTRACT Objective This study compared the effects of phentermine‐topiramate‐ER (mid‐dose 7.5/46 mg) versus placebo on weight loss and cardiovascular disease (CVD) risk outcomes when used as an adjunct to a digitally enhanced lifestyle intervention (DELI).
Alejandro Campos, Wissam Ghusn, Lizeth Cifuentes, Daniel Sacoto, Sima Fansa, Diego Anazco, Maria L. Ricardo‐Silgado, Anas Hashem, Megan Schaefer, William S. Harmsen, Heather J. Gunn, Craig Peterson, Deborah Larsen, Santosh T. Varghese, Maria D. Hurtado, Andres Acosta   +15 more
wiley   +1 more source

One-hour postload glucose compared to prediabetes criteria as predictive markers of type 2 diabetes in Latin America. [PDF]

J Endocr Soc
Lizarzaburu-Robles JC, Herman WH, Garro-Mendiola A, Mahillo-Fernandez I, Lazo-Porras M, Mas-Fontao S, Paniagua A, Vázquez-Matínez C, Vento F, Valera J, Lorenzo O.   +10 more
europepmc   +1 more source